Position in ABVX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$16,293,300
New position
Shares Held
122,267
first reported quarter
Ownership
0.140%
of shares outstanding
% of Portfolio
6.24%
of 13F equity value
Holder Rank
#68
of 301 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Derivatives in ABVX
reported options exposure · as of Jun 30, 2026CallValue
$8,888,442
CallShares
66,700
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026DG Capital Management, LLC holds $32,503,374 across 3 Biotechnology names. ABVX ranks #1 (50.1% of the industry book) .
All Filings in ABVX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,293,300 | 122,267 | Shares | Sole | 2026-08-12 | |
| 2026-06-30 | $8,888,442 | 66,700 | Call | Sole | 2026-08-12 | |
| No filing history on record for this holder in this stock. | ||||||